114 related articles for article (PubMed ID: 9973420)
21. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex.
Jones DE; Palmer JM; Burt AD; Walker C; Robe AJ; Kirby JA
Hepatology; 2002 Sep; 36(3):679-86. PubMed ID: 12198661
[TBL] [Abstract][Full Text] [Related]
22. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
Linghua Z; Xingshan T; Fengzhen Z
Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
[TBL] [Abstract][Full Text] [Related]
23. CpG DNA is an effective oral adjuvant to protein antigens in mice.
McCluskie MJ; Weeratna RD; Krieg AM; Davis HL
Vaccine; 2000 Nov; 19(7-8):950-7. PubMed ID: 11115721
[TBL] [Abstract][Full Text] [Related]
24. Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma.
Mousavi T; Salek Moghadam A; Falak R; Tebyanian M
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):1-6. PubMed ID: 18322305
[TBL] [Abstract][Full Text] [Related]
25. CpG oligodeoxynucleotides augment the immune responses of piglets to swine Pasteurella multocida living vaccine in vivo.
Zhang L; Tian X; Zhou F
Res Vet Sci; 2007 Oct; 83(2):171-81. PubMed ID: 17223146
[TBL] [Abstract][Full Text] [Related]
26. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
[TBL] [Abstract][Full Text] [Related]
27. Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors.
Parronchi P; Brugnolo F; Annunziato F; Manuelli C; Sampognaro S; Mavilia C; Romagnani S; Maggi E
J Immunol; 1999 Dec; 163(11):5946-53. PubMed ID: 10570281
[TBL] [Abstract][Full Text] [Related]
28. Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance.
Cheng X; Chen Y; Xie JJ; Yao R; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH; Cheng Y
J Mol Cell Cardiol; 2008 Aug; 45(2):168-75. PubMed ID: 18502445
[TBL] [Abstract][Full Text] [Related]
29. CpG motifs for optimization of DNA vaccines.
Davis HL
Dev Biol (Basel); 2000; 104():165-9. PubMed ID: 11713816
[TBL] [Abstract][Full Text] [Related]
30. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW
J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136
[TBL] [Abstract][Full Text] [Related]
31. HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses.
Roohvand F; Aghasadeghi MR; Sadat SM; Budkowska A; Khabiri AR
Biochem Biophys Res Commun; 2007 Mar; 354(3):641-9. PubMed ID: 17250802
[TBL] [Abstract][Full Text] [Related]
32. Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Clin Chem Lab Med; 1999 Mar; 37(3):199-204. PubMed ID: 10353461
[TBL] [Abstract][Full Text] [Related]
33. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life.
Martinez X; Brandt C; Saddallah F; Tougne C; Barrios C; Wild F; Dougan G; Lambert PH; Siegrist CA
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8726-31. PubMed ID: 9238045
[TBL] [Abstract][Full Text] [Related]
34. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.
McCluskie MJ; Weeratna RD; Davis HL
Vaccine; 2001 Mar; 19(17-19):2657-60. PubMed ID: 11257405
[TBL] [Abstract][Full Text] [Related]
35. Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein.
Rao M; Matyas GR; Vancott TC; Birx DL; Alving CR
Immunol Cell Biol; 2004 Oct; 82(5):523-30. PubMed ID: 15479438
[TBL] [Abstract][Full Text] [Related]
36. Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner.
Sano K; Shirota H; Terui T; Hattori T; Tamura G
J Immunol; 2003 Mar; 170(5):2367-73. PubMed ID: 12594259
[TBL] [Abstract][Full Text] [Related]
37. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants.
McCluskie MJ; Davis HL
Vaccine; 2000 Oct; 19(4-5):413-22. PubMed ID: 11027803
[TBL] [Abstract][Full Text] [Related]
38. Regulation of T-helper type 2 cell and airway eosinophilia by transmucosal coadministration of antigen and oligodeoxynucleotides containing CpG motifs.
Shirota H; Sano K; Kikuchi T; Tamura G; Shirato K
Am J Respir Cell Mol Biol; 2000 Feb; 22(2):176-82. PubMed ID: 10657938
[TBL] [Abstract][Full Text] [Related]
39. CpG motifs in bacterial DNA and their immune effects.
Krieg AM
Annu Rev Immunol; 2002; 20():709-60. PubMed ID: 11861616
[TBL] [Abstract][Full Text] [Related]
40. Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects.
Barrios C; Brandt C; Berney M; Lambert PH; Siegrist CA
Eur J Immunol; 1996 Nov; 26(11):2666-70. PubMed ID: 8921953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
